Lv1
40 积分 2023-07-05 加入
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
9小时前
待确认
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
10天前
已完结
Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease
2个月前
已完结
Genetically engineered hypoimmunogenic cell therapy
4个月前
已完结
Cell–drug conjugates
6个月前
已完结
Revised “hPSC-Sac Method” for Simple and Efficient Differentiation of Human Pluripotent Stem Cells to Hematopoietic Progenitor Cells
8个月前
已完结
Revised “hPSC-Sac Method” for Simple and Efficient Differentiation of Human Pluripotent Stem Cells to Hematopoietic Progenitor Cells
8个月前
已关闭
iPLAT1: The first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study
1年前
已完结
iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
1年前
已完结
TGF-β Signaling in Stem Cell Regulation
1年前
已完结
皖公网安备34019202002308
